文献速递运动医学关节外科

肩峰下球囊间隔器治疗不可修复肩袖撕裂的组序贯多中心随机对照试验(START:REACTS)两年随访

Two-Year Follow-up of a Group-Sequential, Multicenter Randomized Controlled Trial of a Subacromial Balloon Spacer for Irreparable Rotator Cuff Tears of the Shoulder (START:REACTS).
PubMed 文献 · Am J Sports Med · 2025-03-28

START:REACTS试验将117例不可修复肩袖撕裂患者随机分至仅清创+肱二头肌切断组或加用肩峰下球囊间隔器组,24个月随访99例(85%)。24个月时牛津肩评分无显著差异,西安大略肩袖评分和患者整体印象变化显著 favoring 仅清创组,EQ-5D-5L和满意度无显著差异,并发症两组相当。作者结论为不推荐肩峰下球囊间隔器用于不可修复肩袖撕裂。

要点

  • 24个月时牛津肩评分组间无显著差异(95%CI -7.9至0.4;P=0.08)。
  • 西安大略肩袖评分(均差-10.1;95%CI -19.5至-0.8;P=0.04)和患者整体印象变化(OR 0.4;95%CI 0.2至0.8;P=0.015)显著 favoring 仅清创组。
  • 作者不推荐肩峰下球囊间隔器用于不可修复肩袖撕裂。

核心结论

  • 与加用InSpace球囊组相比,仅清创组持续显示更好的结果,因此作者不推荐肩峰下球囊间隔器用于不可修复肩袖撕裂。

研究设计与样本

  • 组序贯、多中心随机对照试验,证据等级1级;纳入不可修复肩袖撕裂、有需手术的侵入性症状且既往非手术治疗失败的患者,按1:1随机至肩峰下间隙清创+肱二头肌切断(仅清创)或相同操作加肩峰下球囊间隔器(清创+装置)。
  • 计划中期分析时提前终止招募,共117例参与者;117例中99例(85%)随访至24个月;采用线性回归模型分析24个月数据。

主要发现

  • 24个月时牛津肩评分未发现显著差异(95%CI -7.9至0.4;P=0.08)。
  • 西安大略肩袖评分(均差-10.1;95%CI -19.5至-0.8;P=0.04)和患者整体印象变化(比值比0.4;95%CI 0.2至0.8;P=0.015)显著 favoring 仅清创组。
  • EQ-5D-5L(均差-0.009;95%CI -0.107至0.088;P=0.85)和满意度评分(比值比0.6;95%CI 0.3至-1.2;P=0.14)无显著差异。
  • 24个月内并发症在两组间均匀匹配。

关键数值与推荐

  • 牛津肩评分:24个月时组间差异无统计学显著(95%CI -7.9至0.4;P=0.08)。
  • 西安大略肩袖评分:均差-10.1(95%CI -19.5至-0.8;P=0.04),显著 favoring 仅清创组。
  • 患者整体印象变化:比值比0.4(95%CI 0.2至0.8;P=0.015),显著 favoring 仅清创组。
  • EQ-5D-5L:均差-0.009(95%CI -0.107至0.088;P=0.85),无显著差异。
  • 满意度评分:比值比0.6(95%CI 0.3至-1.2;P=0.14),无显著差异。

临床怎么用

  • 作者基于24个月结果不推荐肩峰下球囊间隔器用于不可修复肩袖撕裂的治疗。

局限性

  • 招募在计划中期分析时提前停止,共117例参与者。
  • 117例中仅99例(85%)随访至24个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The best management of irreparable rotator cuff tears remains uncertain, with multiple new techniques introduced over the past 2 decades. Two options for treatment are arthroscopic debridement and biceps tenotomy, or the subacromial balloon spacer. Early trial results favored the former option, but the 2-year results have not yet been reported. PURPOSE: To report the 2-year follow-up outcomes of the START:REACTS trial, investigating the use of a subacromial balloon spacer for irreparable rotator cuff tears of the shoulder. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: Eligible participants had an irreparable rotator cuff tear, intrusive symptoms requiring surgery, and previous unsuccessful nonoperative care. Participants were randomized 1:1 to debridement of the subacromial space with biceps tenotomy (debridement only) or the same procedure with the addition of the subacromial balloon spacer (debridement with device). The 12-month primary outcome was previously reported; this article presents the 24-month results. Linear regression models were used to analyze the 24-month data. RESULTS: Recruitment stopped early at the preplanned interim analysis, with 117 participants in the trial. A total of 99 (85%) participants out of 117 were followed up to 24 months. At 24 months, a significant difference in the Oxford Shoulder Score was not found (95% CI, -7.9 to 0.4; P = .08). The Western Ontario Rotator Cuff score (mean difference, -10.1; 95% CI, -19.5 to -0.8; P = .04) and Patient Global Impression of Change (odds ratio, 0.4; 95% CI, 0.2 to 0.8; P = .015) were found to significantly favor debridement only. The EQ-5D-5L (mean difference, -0.009; 95% CI, -0.107 to 0.088; P = .85) and satisfaction scores (odds ratio, 0.6; 95% CI, 0.3 to -1.2; P = .14) were not significantly different. Complications were evenly matched between groups over 24 months. CONCLUSION: Participants continued to show better results in the debridement-only group compared with the group who had debridement with the InSpace balloon. Therefore, we do not recommend the subacromial balloon spacer for the treatment of irreparable rotator cuff tears.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Haque A, Parsons H, Parsons N, et al. Two-Year Follow-up of a Group-Sequential, Multicenter Randomized Controlled Trial of a Subacromial Balloon Spacer for Irreparable Rotator Cuff Tears of the Shoulder (START:REACTS). Am J Sports Med. 2025. PMID: 40156172. doi:10.1177/03635465251326891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。